阿片类药物预处理调节修复反应以预防肾缺血再灌注损伤。

Opioid Preconditioning Modulates Repair Responses to Prevent Renal Ischemia-Reperfusion Injury.

作者信息

Franco-Acevedo Adriana, Echavarria Raquel, Moreno-Carranza Bibiana, Ortiz Cesar-Ivan, Garcia David, Gonzalez-Gonzalez Ricardo, Bitzer-Quintero Oscar-Kurt, Portilla-De Buen Eliseo, Melo Zesergio

机构信息

Doctorado en Farmacologia, Universidad de Guadalajara, Guadalajara 44340, Mexico.

CONACyT-Centro de Investigacion Biomedica de Occidente, Instituto Mexicano de Seguro Social, Guadalajara 44340, Mexico.

出版信息

Pharmaceuticals (Basel). 2020 Nov 14;13(11):387. doi: 10.3390/ph13110387.

Abstract

Progression to renal damage by ischemia-reperfusion injury (IRI) is the result of the dysregulation of various tissue damage repair mechanisms. Anesthetic preconditioning with opioids has been shown to be beneficial in myocardial IRI models. Our main objective was to analyze the influence of pharmacological preconditioning with opioids in renal function and expression of molecules involved in tissue repair and angiogenesis. Experimental protocol includes male rats with 45 min ischemia occluding the left renal hilum followed by 24 h of reperfusion with or without 60 min preconditioning with morphine/fentanyl. We analyzed serum creatinine and renal expression. We measured circulating and intrarenal VEGF. Immunohistochemistry for HIF-1 and Cathepsin D (CTD) and real-time PCR for angiogenic genes , , VEGF Receptor 2 (), , and were performed. These molecules are considered important effectors of tissue repair responses mediated by the development of new blood vessels. We observed a decrease in acute renal injury mediated by pharmacological preconditioning with opioids. Renal function in opioid preconditioning groups was like in the sham control group. Both anesthetics modulated the expression of HIF-1, VEGF, VEGF-R2 and CD31. Preconditioning negatively regulated CTD. Opioid preconditioning decreased injury through modulation of angiogenic molecule expression. These are factors to consider when establishing strategies in pathophysiological and surgical processes.

摘要

缺血再灌注损伤(IRI)导致的肾损伤进展是多种组织损伤修复机制失调的结果。在心肌IRI模型中,阿片类药物进行麻醉预处理已被证明是有益的。我们的主要目的是分析阿片类药物进行药理学预处理对肾功能以及参与组织修复和血管生成的分子表达的影响。实验方案包括对雄性大鼠左肾蒂进行45分钟的缺血,然后在有或没有用吗啡/芬太尼进行60分钟预处理的情况下进行24小时的再灌注。我们分析了血清肌酐和肾脏表达。我们测量了循环和肾内血管内皮生长因子(VEGF)。进行了缺氧诱导因子-1(HIF-1)和组织蛋白酶D(CTD)的免疫组织化学以及血管生成基因、、VEGF受体2()、、和的实时聚合酶链反应(PCR)。这些分子被认为是由新血管生成介导的组织修复反应的重要效应器。我们观察到阿片类药物进行药理学预处理介导的急性肾损伤有所减少。阿片类药物预处理组的肾功能与假手术对照组相似。两种麻醉剂都调节了HIF-1、VEGF、VEGF-R2和CD31的表达。预处理对CTD起到负调节作用。阿片类药物预处理通过调节血管生成分子的表达减少损伤。在制定病理生理和手术过程中的策略时,这些都是需要考虑的因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10de/7696679/730ff69e50a1/pharmaceuticals-13-00387-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索